The estimated Net Worth of Robert A Wychulis is at least $12.4 Millón dollars as of 5 March 2020. Mr. Wychulis owns over 16,071 units of Innovator ETFs Trust stock worth over $8,267,502 and over the last 10 years he sold INOV stock worth over $2,841,499. In addition, he makes $1,258,830 as President at Innovator ETFs Trust.
Sign up
Mr. Wychulis INOV stock SEC Form 4 insiders trading
Robert has made over 5 trades of the Innovator ETFs Trust stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 16,071 units of INOV stock worth $308,402 on 5 March 2020.
The largest trade he's ever made was selling 85,828 units of Innovator ETFs Trust stock on 4 December 2017 worth over $1,333,767. On average, Robert trades about 5,653 units every 49 days since 2015. As of 5 March 2020 he still owns at least 284,009 units of Innovator ETFs Trust stock.
You can see the complete history of Mr. Wychulis stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Wychulis biography
Robert A. Wychulis is President of the INOVALON HOLDINGS, INC since May 2014. In this role, Mr. Wychulis is responsible for the oversight of each of the business segment subsidiaries, the product groups of the Company, and the related support of industry insight, client engagement, and strategic relationships. Prior to joining Inovalon, from 2008 to May 2014, Mr. Wychulis served as the President of the WellPoint New York government program health plan, HealthPlus, an Amerigroup company, where he was responsible for the management of the company’s product portfolio within the New York region. Prior to joining WellPoint/Amerigroup, from 2003 to 2008, Mr. Wychulis served as President and CEO of the Florida Association of Health Plans, where he grew the association from eight to 26 plans in four years. From 1995 to 2002, Mr. Wychulis served as President and CEO of HealthPlan Southeast, a North Florida managed care company comprised of state employee, commercial and Medicaid/CHP contracts. Mr. Wychulis received his Bachelor of Political Science degree from the City College of New York and his Masters of Health Administration and Planning from the Wagner School of Public Administration at New York University.
What is the salary of Robert Wychulis?
As the President of Innovator ETFs Trust, the total compensation of Robert Wychulis at Innovator ETFs Trust is $1,258,830. There are 3 executives at Innovator ETFs Trust getting paid more, with Peter De Bock having the highest compensation of $2,866,730.
How old is Robert Wychulis?
Robert Wychulis is 65, he's been the President of Innovator ETFs Trust since 2014. There are 5 older and 7 younger executives at Innovator ETFs Trust. The oldest executive at Innovator ETFs Trust is Denise Fletcher, 71, who is the Independent Director.
What's Robert Wychulis's mailing address?
Robert's mailing address filed with the SEC is 4321, Collington Road, Essington, Bowie, Prince George's County, Maryland, 20716, United States.
Insiders trading at Innovator ETFs Trust
Over the last 10 years, insiders at Innovator ETFs Trust have traded over $17,222,256 worth of Innovator ETFs Trust stock and bought 1,096,675 units worth $14,934,745 . The most active insiders traders include Keith R Dunleavy, Christopher E Greiner y William D Green. On average, Innovator ETFs Trust executives and independent directors trade stock every 36 days with the average trade being worth of $987,207. The most recent stock trade was executed by William J Jr Teuber on 18 June 2021, trading 9,165 units of INOV stock currently worth $266,793.
What does Innovator ETFs Trust's logo look like?
Complete history of Mr. Wychulis stock trades at Innovator ETFs Trust
Innovator ETFs Trust executives and stock owners
Innovator ETFs Trust executives and other stock owners filed with the SEC include:
-
Peter De Bock,
Chief Administrative Officer -
Jonathan Boldt,
Chief Financial Officer -
Jason Capitel,
Chief Operating Officer -
Robert Wychulis,
President -
Isaac Kohane,
Independent Director -
William Teuber,
Independent Director -
Lee Roberts,
Independent Director -
William Green,
Independent Director -
Denise Fletcher,
Independent Director -
Mark Pulido,
Non-Independent Director -
Dr. Keith R. Dunleavy,
Founder, Chairman & CEO -
Keith Dunleavy,
Chairman of the Board, Chief Executive Officer -
Andre Hoffmann,
Independent Director -
Dr. Paige C. Kilian M.D.,
Chief Medical Officer -
Ingrid E. Olsen,
Chief People Officer -
Kim E. Collins,
Sr. VP of Corp. Marketing & Communications -
Beverly Allen,
Gen. Counsel, Chief Compliance & Privacy Officer -
Hulus Alpay,
VP of Investor Relations -
Geoff Charron,
Chief Technology Officer -
June Duchesne,
Chief Legal Officer -
Shauna L Vernal,
Chief Legal Officer -
Joseph R Rostock,
Chief Technology Officer -
Daniel L Rizzo,
Chief Innovation Officer -
Thomas R Kloster,
Chief Financial Officer -
Christopher E Greiner,
Chief Product Officer & COO -
John Michael Burgin,
Chief Product Officer -
Eron Kelly,
President